PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Program in Cellular and Molecular Medicine, Boston Children\'s Hospital, Boston, MA.\', \'Department of Pediatrics, Harvard Medical School, Boston, MA.\', \'Whitman Center, Marine Biological Laboratory, Woods Hole, MA.\', \'Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women\'s Hospital and Harvard Medical School, Boston, MA.\', \'Department of Cardiology and Angiology, University of Tübingen, Tübingen, Germany.\', \'Department of Medicine, Brigham and Women\'s Hospital, Boston, MA.\', \'Division of Infectious Diseases, Centre Hospitalier de l\'Université de Montréal, Montreal, Quebec, Canada.\', \'Division of Pulmonary Medicine, and.\', \'Division of Pulmonary Medicine, Department of Pediatrics, Boston Children\'s Hospital, Boston, MA.\', \'Department of Pediatric Newborn Medicine, and.\', \'Department of Surgery, Brigham and Women\'s Hospital and Harvard Medical School, Boston, MA; and.\', \'Division of Hematology/Oncology, Boston Children\'s Hospital, Boston, MA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1182/bloodadvances.2021005949
?:doi
?:hasPublicationType
?:journal
  • Blood advances
is ?:pmid of
?:pmid
?:pmid
  • 34991159
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Inflammasome activation in neutrophils of patients with severe COVID-19.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all